Fengbo Mo

546 total citations
29 papers, 373 citations indexed

About

Fengbo Mo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fengbo Mo has authored 29 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fengbo Mo's work include Cancer-related molecular mechanisms research (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Bone Metabolism and Diseases (3 papers). Fengbo Mo is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Bone Metabolism and Diseases (3 papers). Fengbo Mo collaborates with scholars based in China and United States. Fengbo Mo's co-authors include Xianzhe Liu, Shuhua Yang, Zhibo Sun, Xianyi Cai, Wenda Zhang, Jinglong Wang, Shunan Ye, Qiuyue Ding, Cheng Cheng and Shengqing Hu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Experimental Cell Research.

In The Last Decade

Fengbo Mo

26 papers receiving 371 citations

Peers

Fengbo Mo

ONCOL

OSM

SURGE

Zhigang Nie China

Junjie Niu China

Simone Donati Italy

Jeong-Tae Koh South Korea

Hongsong Fang China

Xiangde Zhao China

Zhihua Wen China

Maya Fakhry Lebanon

Fengxiang Pang China

Marika Bergenstock United States

Zhigang Nie China

Fengbo Mo

182 ×0.9

77 ×0.7

78 ×1.0

ONCOL

85 ×1.3

OSM

27 ×0.5

SURGE

Citations per year, relative to Fengbo Mo Fengbo Mo (= 1×) peers Zhigang Nie

Countries citing papers authored by Fengbo Mo

Since Specialization

Citations

This map shows the geographic impact of Fengbo Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengbo Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengbo Mo more than expected).

Fields of papers citing papers by Fengbo Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengbo Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengbo Mo. The network helps show where Fengbo Mo may publish in the future.

Co-authorship network of co-authors of Fengbo Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Fengbo Mo. A scholar is included among the top collaborators of Fengbo Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengbo Mo. Fengbo Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mao, Hanling, et al.. (2025). Uniform bullseye-guided contrastive learning with time-frequency strong augmentation for long-tailed fault diagnosis. Mechanical Systems and Signal Processing. 230. 112639–112639.

Luo, Peng, Fengbo Mo, Qi Lai, et al.. (2025). Construction of hyperbranched polyglycerol-based curcumin prodrug via phenol-yne click reaction for pH-responsive and bone-targeted osteoporosis therapy. Materials & Design. 261. 115291–115291.

Li, Xinxin, et al.. (2025). Enhanced sparsity via adaptive period estimation and Lp norm for rolling bearing fault feature extraction. Journal of Vibration and Control. 32(5-6). 1119–1131. 1 indexed citations

Huang, Shaorong, Qi Lai, Fengbo Mo, et al.. (2025). Self-assembly of phosphorylated dihydromyricetin as a carrier-free bone targeting nanomedicine with enhanced efficacy for osteoporosis treatment. Materials & Design. 255. 114149–114149.

Li, Xinxin, et al.. (2025). An integrated vibration energy harvesting-storage-injection system based on piezoelectric bistable. Smart Materials and Structures. 34(2). 25024–25024. 2 indexed citations

Zhang, Zhiwei, Bo Li, Yuxin Yang, et al.. (2024). Bergenin protects against osteoarthritis by inhibiting STAT3, NF-κB and Jun pathways and suppressing osteoclastogenesis. Scientific Reports. 14(1). 20292–20292. 3 indexed citations

Xu, Tiantian, et al.. (2024). Analysis of clinical characteristics in patients with diabetic foot ulcers undergoing amputation and establishment of a nomogram prediction model. Scientific Reports. 14(1). 27934–27934. 3 indexed citations

Zhan, Haibo, Jun Xiao, Fan Zou, et al.. (2024). Pluripotent stem cell-derived CTLs targeting FGFR3-TACC3 fusion gene in osteosarcoma. International Immunopharmacology. 142(Pt B). 112862–112862. 1 indexed citations

Li, Xinxin, et al.. (2024). Group sparse low-rank algorithm for ultrasonic guided wave defect feature extraction. Measurement Science and Technology. 36(1). 16184–16184. 2 indexed citations

10.

Xu, Qiang, et al.. (2024). Mechanism of lysine oxidase-like 1 promoting synovial inflammation mediating rheumatoid arthritis development. Aging. 16(1). 928–947. 2 indexed citations

11.

Mo, Fengbo, Qiang Xu, Jian‐Hui Liang, et al.. (2023). ADRM1/RPN13 attenuates cartilage extracellular matrix degradation via enhancing UCH37-mediated ALK5 deubiquitination. International Journal of Biological Macromolecules. 247. 125670–125670. 3 indexed citations

12.

Zhan, Haibo, Weiwei Wu, Zhihui Kuang, et al.. (2023). A comprehensive pan-cancer analysis unveiling the oncogenic effect of plant homeodomain finger protein 14 (PHF14) in human tumors. Frontiers in Genetics. 14. 1073138–1073138. 2 indexed citations

13.

Wang, Song, et al.. (2022). Targeted inhibition of TXNRD1 prevents cartilage extracellular matrix degeneration by activating Nrf2 pathway in osteoarthritis. Biochemical and Biophysical Research Communications. 635. 267–276. 6 indexed citations

14.

Huang, Kai, Min Dai, Fengbo Mo, et al.. (2021). A comparison of monoaxial pedicle screw versus polyaxial pedicle screw in short-segment posterior fixation for the treatment of thoracolumbar fractured vertebra. Annals of Translational Medicine. 9(8). 669–669. 14 indexed citations

15.

Zhan, Haibo, Fengbo Mo, Xiaoyu Xu, et al.. (2021). A SEER-based nomogram accurately predicts prognosis in Ewing’s sarcoma. Scientific Reports. 11(1). 22723–22723. 13 indexed citations

16.

Pan, Zhimin, Fengbo Mo, Hucheng Liu, et al.. (2021). LncRNA prostate androgen-regulated transcript 1 (PART 1) functions as an oncogene in osteosarcoma via sponging miR-20b-5p to upregulate BAMBI. Annals of Translational Medicine. 9(6). 488–488. 4 indexed citations

17.

Xu, Qiang, Xiaofeng Li, Fengbo Mo, et al.. (2021). Bisphosphonate‐enoxacin inhibit osteoclast formation and function by abrogating RANKL‐induced JNK signalling pathways during osteoporosis treatment. Journal of Cellular and Molecular Medicine. 25(21). 10126–10139. 18 indexed citations

18.

Wan, Zongmiao, Sheng Huang, Fengbo Mo, et al.. (2019). CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis. Experimental Cell Research. 384(2). 111646–111646. 10 indexed citations

19.

Sun, Zhibo, Haifan Xiao, Wusheng Kan, et al.. (2014). Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study. Osteoporosis International. 26(1). 187–197. 53 indexed citations

20.

Sun, Zhibo, Shuhua Yang, Shunan Ye, et al.. (2013). Aberrant CpG Islands’ Hypermethylation of ABCB1 in Mesenchymal Stem Cells of Patients with Steroid-associated Osteonecrosis. The Journal of Rheumatology. 40(11). 1913–1920. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact